|
Volumn 37, Issue 9, 2002, Pages 556-558
|
Experimental therapy with angiogenesis inhibitor TNP-470 on human ovarian cancer transplanted subcutaniously in nude mice
a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ALKYLATING AGENT;
ANGIOGENESIS INHIBITOR;
ANTINEOPLASTIC AGENT;
CYCLOHEXANE DERIVATIVE;
CYCLOPHOSPHAMIDE;
FUMAGILLOL CHLOROACETYLCARBAMATE;
O-(CHLOROACETYLCARBAMOYL)FUMAGILLOL;
SESQUITERPENE;
ANIMAL;
ARTICLE;
BODY WEIGHT;
CANCER TRANSPLANTATION;
CELL CULTURE;
CELL DIVISION;
DRUG EFFECT;
DRUG POTENTIATION;
DRUG SCREENING;
FEMALE;
HUMAN;
MOUSE;
NUDE MOUSE;
OVARY TUMOR;
PATHOLOGY;
TIME;
ANGIOGENESIS INHIBITORS;
ANIMALS;
ANTINEOPLASTIC AGENTS, ALKYLATING;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BODY WEIGHT;
CELL DIVISION;
CYCLOHEXANES;
CYCLOPHOSPHAMIDE;
DRUG SYNERGISM;
FEMALE;
HUMANS;
MICE;
MICE, NUDE;
NEOPLASM TRANSPLANTATION;
OVARIAN NEOPLASMS;
SESQUITERPENES;
TIME FACTORS;
TUMOR CELLS, CULTURED;
XENOGRAFT MODEL ANTITUMOR ASSAYS;
|
EID: 0036717705
PISSN: 0529567X
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (1)
|
References (0)
|